Help
Subscribe


All of GastroHep is now free access! - Click here to register Read For FREE - Our full range of review articles
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Guido Tytgat Profile of Pete Peterson Profile of Peter Cotton Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Endoscopic ultrasound in suspected biliary obstruction influences ERCP burden in real clinical practice

A study in this month's issue of the European Journal of Gastroenterology & Hepatology reports on the diagnostic accuracy of endoscopic ultrasound in suspected biliary obstruction and its impact on ERCP burden in real clinical practice.

News image

Performing endoscopic ultrasound before endoscopic retrograde cholangiopancreatography (ERCP) has been described to be useful in cases of suspected biliary obstruction where endoscopic ultrasound can triage patients for endoscopic retrograde cholangiopancreatography.

Dr Zaheer Abdula and colleagues determined the diagnostic accuracy of endoscopic ultrasound and its impact on endoscopic retrograde cholangiopancreatography burden in real clinical practice.

The research team evaluated the safety and efficacy of endoscopic ultrasound+endoscopic retrograde cholangiopancreatography in a single endoscopic session.

The team evaluated 418 consecutive patients with suspected but unexplained biliary obstruction referred for endoscopic ultrasound before possible endoscopic retrograde cholangiopancreatography.

The research team team determined the diagnostic accuracy of endoscopic ultrasound and its value in predicting the need for endoscopic retrograde cholangiopancreatography.

Endoscopic ultrasound established whether pancreaticobiliary disorder was present, and whether therapeutic endoscopic retrograde cholangiopancreatography was required.

Endoscopic ultrasound showed pathology in 42% who had a nondilated biliary system
European Journal of Gastroenterology & Hepatology

These decisions were matched with endoscopic retrograde cholangiopancreatography findings, histology, clinical course, and follow-up.

Where endoscopic retrograde cholangiopancreatography was indicated, it was performed in the same endoscopic session.

Endoscopic ultrasound was performed in 412 out of 418 patients, and endoscopic retrograde cholangiopancreatography was considered necessary in 64%.

The research team noted that the single-session endoscopic ultrasound, and endoscopic retrograde cholangiopancreatography was safe and effective.

The diagnostic accuracy of endoscopic ultrasound included 99% in choledocholithiasis, 90% with malignant strictures, and 92% with benign strictures.

The research team reported that endoscopic ultrasound showed pathology in 42% of patients who had a nondilated biliary system at initial investigations.

When endoscopic ultrasound indicated a normal common bile duct, this had a 100% positive predictive value for non-necessity for endoscopic retrograde cholangiopancreatography.

The median overall follow-up period was 12 months.

Dr Abdula's team commented, "Endoscopic ultrasound demonstrated high diagnostic accuracy in this mixed group of pancreaticobiliary disorder."

"This accurately guided endoscopic retrograde cholangiopancreatography need and avoided unnecessary endoscopic retrograde cholangiopancreatography in 36%."

"endoscopic ultrasound and endoscopic retrograde cholangiopancreatography in the same endoscopic session for the evaluation and management of PBD is technically feasible, with safety and efficacy profiles equivalent to that of each procedure performed independently in different sessions."

Eur J of Gastroenterol & Hepatology: 2013: (25)7 :850-857
21 June 2013

Go to top of page Email this page Email this page to a colleague

 28 February 2015

Advanced search
 27 February 2015 
Obesity and weight-loss therapy
 27 February 2015 
MRE performance in staging liver fibrosis
 27 February 2015 
Bleeding in diverticulosis
 26 February 2015 
Familial colorectal cancer risk and primary cancer
 26 February 2015 
Questionnaires for GERD
 26 February 2015 
Herbal products and the liver
 25 February 2015 
Exercise and NAFLD
 25 February 2015 
IBD in Korea
 25 February 2015 
Immunosuppressive therapy and T. whipplei
 24 February 2015 
Clinical trials in pediatric IBD
 24 February 2015 
Reducing health care costs in IBD
 24 February 2015 
GI bleeding after anticoagulation interruption
 23 February 2015 
Visceral abdominal obesity and IBS
 23 February 2015 
Crohn's outcomes with infliximab
 23 February 2015 
Intestinal microbiota and celiac disease
 20 February 2015 
H. pylori eradication
 20 February 2015 
Antiviral treatment and Hep C outcomes
 20 February 2015 
C. diff testing in IBD
 19 February 2015 
Intestinal microbiota in IBS
 19 February 2015 
Peptic ulcer bleeding mortality in liver disease
 19 February 2015 
Fecal microbial transplant in active Crohn's disease
 18 February 2015 
Genetic testing and GI cancers
 18 February 2015 
Placebo analgesia in functional abdominal pain
 18 February 2015 
Successful Hep C virus therapy
 17 February 2015 
Quality measures and colonoscopist selection
 17 February 2015 
Global incidence of esophageal cancer
 17 February 2015 
Anti-viral treatment and survival in Hep C
 16 February 2015 
Saliva for the diagnosis of GERD
 16 February 2015 
H pylori eradication therapy
 16 February 2015 
Medical marijuana for digestive disorders
 13 February 2015 
Beta-blockers in cirrhosis
 13 February 2015 
Liver disease and peptic ulcer bleeding
 13 February 2015 
Prevalence of microscopic colitis
 12 February 2015 
Liver disease in chronic Hep C
 12 February 2015 
Patient-reported outcomes in Hep C
 12 February 2015 
Patientsí colonoscopist selection
 11 February 2015 
NAFLD and CVD
 11 February 2015 
Guidelines for the diagnosis of hepatocellular carcinoma
 11 February 2015 
Hepatic decompensation in Hep C cirrhosis
 10 February 2015 
Percutaneous endoscopic gastrostomy
 10 February 2015 
Factors that influence hepatic steatosis
 10 February 2015 
Gene variants and Crohn's susceptibility
 09 February 2015 
Factors that influence gallstone surgery
 09 February 2015 
Factors associated with increased mortality in cirrhosis
 09 February 2015 
Use of immunomodulators in IBD
 06 February 2015 
Colorectal cancer risk in IBD
 06 February 2015 
H. pylori and peptic ulcer bleeding
 06 February 2015 
IBS and somatization
 05 February 2015 
GERD, dyspepsia and IBS symptoms
 05 February 2015 
Quality of life in Crohn's after antitumor necrosis factor agents
 05 February 2015 
Thalidomide and refractory Crohn's
 04 February 2015 
Telemedicine in IBD
 04 February 2015 
Infliximab and muscle wasting in Crohn's
 04 February 2015 
Resistance mutations in chronic Hep B
 03 February 2015 
Testosterone in advanced liver disease
 03 February 2015 
Mortality in peptic ulcer bleeding
 03 February 2015 
Colonoscopic remission of ulcerative colitis
 02 February 2015 
Colonoscopy and colon cancer risk in IBD
 02 February 2015 
Sirolimus in Hep C virus infected liver graft recipients
 02 February 2015 
Treatment of C. diff in adults

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2015 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us